Oral H1 antihistamines as monotherapy for eczema

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 2, 2013, Pages

  Apfelbacher, Christian J ^a   van Zuuren, Esther J ^b   Fedorowicz, Zbys ^c   Jupiter, Aldrin ^d   Matterne, Uwe ^d   Weisshaar, Elke ^d  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Bahrain Branch   (Bahrain)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; PLACEBO; HISTAMINE H1 RECEPTOR ANTAGONIST;

DISEASE SEVERITY; DRUG EFFECT; ECZEMA; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCORAD; SIDE EFFECT; SKIN DISEASE ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VISUAL ANALOG SCALE; ADOLESCENT; ADULT; CHILD; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CHILD; ECZEMA; HISTAMINE H1 ANTAGONISTS; HUMANS;

MLCS; MLOWN;

EID: 84875506820     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007770.pub2     Document Type: Review

References (66)

1. Baraf CS. Treatment of Pruritus in Allergic Dermatoses: An Evaluation of the Relative Efficacy of Cyproheptadine and Hydroxyzine. Current Therapeutic Research, Clinical & Experimental 1976;19(1):32-8. [MEDLINE: 812662]
2. Berth-Jones J, Graham-Brown RA. Failure of terfenadine in relieving the pruritus of atopic dermatitis. British Journal of Dermatology 1989;121(5):635-7. [MEDLINE: 2574594]
3. Castro Torres A, Martin Moreno L, Jimenez Reyes J, Bucher Y. Double-blind study terfenadine versus clemastine in pruriginous skin disorders [Terfenadina frente a clemastina en el tratamiento de las enfermedades cutáneas pruriginosas. Estudio comparativo doble-ciego]. Revista Clinica Espanola 1987;181(8):410-2. [MEDLINE: 2894043]
4. Doherty V, Sylvester DG, Kennedy CT, Harvey SG, Calthrop JG, Gibson JR, et al. Treatment of itching in atopic eczema with antihistamines with a low sedative profile. BMJ 1989;298(6666):96. [MEDLINE: 2563952]
5. Falk ES. Ketotifen in the treatment of atopic dermatitis. Results of a double blind study. European Review for Medical & Pharmacological Sciences (Rivista Europea Per Le Scienze Mediche e Farmacologiche) 1993;15(2):63-6. [MEDLINE: 8171216]
6. Foulds IS, MacKie RM. A double-blind trial of the H2 receptor antagonist cimetidine, and the H1 receptor antagonist promethazine hydrochloride in the treatment of atopic dermatitis. Clinical Allergy 1981;11(4):319-23. [MEDLINE: 7028312]
7. Hamada T, Ishii M, Nakagawa K, Kobayashi H, Kitajima J, Chanoki M, et al. Evaluation of the clinical effect of terfenadine in patients with atopic dermatitis. A comparison of strong corticosteroid therapy to mild topical corticosteroid combined with terfenadine administration therapy. Skin Research 1996;38(1):97-103. [EMBASE: 1996118577]
8. Henz BM, Metzenauer P, O'Keefe E, Zuberbier T. Differential effects of new-generation H1-receptor antagonists in pruritic dermatoses. Allergy 1998;53(2):180-3. [MEDLINE: 9534917]
9. Hjorth N. Terfenadine in the treatment of chronic idiopathic urticaria and atopic dermatitis. Cutis 1988;42(4A):29-30. [MEDLINE: 2903817]
10. Kawashima M, Tango T, Noguchi T, Inagi M, Nakagawa H, Harada S, et al. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. British Journal of Dermatology 2003;148(6):1212-21. [MEDLINE: 12828751]
11. Kawashima M, Nakagawa H. Olopatadine hydrochloride in children: Evidenced efficacy and safety for atopic dermatitis treatment in a randomized, multicenter, double-blind, parallel group comparative study. Nishinihon Journal of Dermatology 2011;73(3):278-89. [EMBASE: 2011412534]
12. Kimura U, Matsuba S, Chikenji T, Haruna K, Kamano M, Suga, Y, et al. Usefulness of TARC in serum as treatment marker and combination treatment with loratadine and steroid ointment for atopic dermatitis. Skin Research 2009;8(2):125-31. [EMBASE: 2010000252]
13. Klein GL, Galant SP. A comparison of the antipruritic efficacy of hydroxyzine and cyproheptadine in children with atopic dermatitis. Annals of Allergy 1980;44(3):142-5. [MEDLINE: 7362092]
14. Kuniyuki S, Yoshida Y, Maekawa N, Yamanaka K. Examination of olopatadine hydrochloride for anti-itching and topical-steroid sparing effects in patients with chronic eczema or dermatitis. Nishinihon Journal of Dermatology 2009;71(5):526-30. [EMBASE: 2009581673]
15. La Rosa M, Ranno C, Musarra I, Guglielmo F, Corrias A, Bellanti JA. Double-blind study of cetirizine in atopic eczema in children. Annals of Allergy 1994;73(2):117-22. [MEDLINE: 8067594]
16. Michel L, De Vos C, Dubertret L. Cetirizine effects on the cutaneous allergic reaction in humans. Annals of Allergy 1990;65(5):512-6. [MEDLINE: 1979475]
17. Monroe EW. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis. Clinical Therapeutics 1992;14(1):17-21. [MEDLINE: 1349509]
18. Munday J, Bloomfield R, Goldman M, Robey H, Kitowska GJ, Gwiezdziski Z, et al. Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component. Dermatology 2002;205(1):40-5. [MEDLINE: 12145433]
19. Nakagawa H, Kawashima M. Efficacy and safety of fexofenadine hydrochloride in pediatric patients with atopic dermatitis in a phase III, randomized, double-blind, multi-center comparative study. Nishinihon Journal of Dermatology 2006;68(5):553-65. [EMBASE: 2006521484]
20. Nakayama Y, Akasaka T, Baba M, Iwasaki E, Funahashi S, Nishimuta T, et al. A double blind controlled trial of azatidine maleate syrup (idulamine syrup) in children with urticaria or atopic dermatitis. Comparison of effectiveness and side effect with d chlorpheniramine maleate syrup. Rinsho Hyoka: Clinical Evaluation 1980;8(1):235-78. [CENTRAL: CN-00268192]
21. Nuovo J, Ellsworth AJ, Larson EB. Treatment of Atopic Dermatitis With Antihistamines: Lessons from A Single-Patient, Randomized Clinical Trial. Journal of the American Board of Family Practice 1992;5(2):137-41. [MEDLINE: 1575065]
22. Patel P, Gratton D, Eckstein G, Aberer W, Pryzbilla B, Chelly M, et al. A double-blind study of loratadine and cetirizine in atopic dermatitis. Journal of Dermatological Treatment 1997;8(4):249-53. [EMBASE: 1998022646]
23. Ruzicka T, Karmann B, Kowok K, Altmeyer P. Atopisches Ekzem: Behandlung mit Loratadin. Der Deutsche Dermatologe 1998;46(4):1-8.
24. Savin JA, Paterson WD, Adam K, Oswald I. Effects of Trimeprazine and Trimipramine on Nocturnal Scratching in Patients with Atopic Eczema. Archives of Dermatology 1979;115(3):313-5. [MEDLINE: 373632]
25. Savin JA, Dow R, Harlow BJ, Massey H, Yee KF. The effect of a new non-sedative H1-receptor antagonist (LN2974) on the itching and scratching of patients with atopic eczema. Clinical & Experimental Dermatology 1986;11(6):600-2. [MEDLINE: 2889550]
26. Sheng N, Zong W-K, Yu M-W, Lin L, Cui P-G. The clinical and immunological study of the mizolastine on the eczema and atopic dermatitis. Journal of Clinical Dermatology 2009;38(7):440-2. [EMBASE: 2010312975]
27. Simons FE, Early Prevention of Asthma in Atopic Children (EPAAC) Study Group. Safety of levocetirizine treatment in young atopic children: An 18-month study. Pediatric Allergy & Immunology 2007;18(6):535-42. [MEDLINE: 17561929]
28. Sugai J, Kakurai M, Otsuki M, Nakagawa H. Combination therapy with 0.1% tacrolimus ointment and cetirizine for facial atopic dermatitis [Abstract P2-8]. The 12th Congress of the European Academy of Dermatology and Venereology, Barcelona, Spain 15-18th October 2003. Journal of the European Academy of Dermatology & Venereology 2003;17(Suppl 3):174.
29. Tarchalska B, Zawisza E. A new generation of antihistaminics (H1) [Nowa generacja leków przeciwhistaminowych (H1)]. Polski Tygodnik Lekarski 1988;43(51-52):1672-5. [MEDLINE: 2908342]
30. Tharp MD, Lowe NJ, Soter N, Kramer B. A Double-blind Parallel Study of Cetirizine (C) 20 mg and Placebo (P) in the Management of Patients with Atopic Dermatitis [P 41]. Annals of Allergy, Asthma, & Immunology 1998;80:110. [CENTRAL: CN-00285014]
31. Tholen S, Dieterich HA. Terfenadine versus ketotifen in children with atopic dermatitis [Terfendain versus ketotifen bei kindern mit atopischer dermatitis]. Allergologie 1989;12(2):60-3. [EMBASE: 1989063112]
32. Wahlgren CF, Hägermark O, Bergström R. The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis. British Journal of Dermatology 1990;122(4):545-51. [MEDLINE: 2110817]
33. Wolfram S. Clinical experience with a new antihistaminic [Klinische Erfahrunge mit einem neuen Antihistaminikum]. Wiener Medizinische Wochenschrift 1967;117(38):868-70. [MEDLINE: 4385553]
34. Zhang SF, Zhang TD, Qiu XW, Zhan QS. 36 cases of terfenadine combining with IFN-gamma for atopic dermatitis. Chinese Journal of Dermatovenereology 1998;12(2):85-6.
35. Zimmermann B, Fischer H. Antipruritic or anti-allergic therapy. The efficacy and tolerance of intravenous dimethindenmaleate [Antipruriginöse bzw. antiallergische Therapie - Zur Wirksamkeit und Verträglichkeit von Dimetindenmaleat bei intravenöser Verabreichung]. Fortschritte der Medizin 1981;99(35):1418-20. [MEDLINE: 7024069]
36. Kircik L. Management of pruritus with levocetirizine dihydrochloride in atopic dermatitis in a randomized, double-blind, placebo controlled study - Interim analysis of 21 subjects. Western Society of Allergy, Asthma, and Immunology Meeting Lnai, HI United States, 24-28 January 2010. Allergy & Asthma Proceedings 2010;31(2):166. [EMBASE: 70168639]
37. Brown P, Brunnhuber K, Chalkidou K, Chalmers I, Clarke M, Fenton M, et al. How to formulate research recommendations. BMJ 2006;333(7572):804-6. [MEDLINE: 17038740]
38. Dawn A, Papoiu AD, Chan YH, Rapp SR, Rassette N, Yosipovitch G. Itch characteristics in atopic dermatitis: results of a web-based questionnaire. British Journal of Dermatology 2009;160(3):42-4. [PUBMED: 19067703]
39. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34. [PUBMED: 9310563]
40. Engman M, Weiss R, Engman MJ. Eczema and environment. Medical Clinics of North America 1936;20:651-63.
41. No authors listed. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186(1):23-31. [MEDLINE: 8435513]
42. Greaves MW. Antihistamines. Dermatologic Clinics 2001;19(1):53-62. [MEDLINE: 11155586]
43. Greaves MW. Antihistamines in dermatology. Skin Pharmacology & Physiology 2005;18(5):220-9. [PUBMED: 16015020]
44. Handley DA, Magnetti A, Higgins AJ. Therapeutic advantages of third generation antihistamines. Expert Opinion on Investigational Drugs 1998;7(7):1045-54. [MEDLINE: 15992014]
45. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermato-Venereologica 1980;92(Suppl):44-7.
46. Herman SM, Vender RB. Antihistamines in the treatment of dermatitis. Journal of Cutaneous Medicine & Surgery 2003;7(6):467-73. [MEDLINE: 15926215]
47. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
48. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. Journal of Allergy & Clinical Immunology 2004;113(5):832-6. [MEDLINE: 15131563]
49. Kay GG. The effects of antihistamines on cognition and performance. Journal of Allergy & Clinical Immunology 2000;105(6 Pt 2):S622-7. [PUBMED: 10856168]
50. Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Archives of Dermatology 1999;135(12):1522-5. [MEDLINE: 10606058]
51. Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. Journal of Allergy & Clinical Immunology 2009;124(6):1251-8.e23. [PUBMED: 20004783]
52. Reitamo S, Ansel JC, Luger TA. Itch in atopic dermatitis. Journal of the American Academy of Dermatology 2001;45(1 Suppl):S55-6. [MEDLINE: 11423876]
53. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
54. Rukwied R, Lischetzki G, McGlone F, Heyer G, Schmelz M. Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. British Journal of Dermatology 2000;142(6):1114-20. [MEDLINE: 10848733]
55. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989;95(2 Suppl):2S-4S. [MEDLINE: 2914516]
56. Schmitt J, Langan S, Williams HC, European Dermato-Epidemiology Network. What are the best outcome measurements for atopic eczema? A systematic review. Journal of Allergy and Clinical Immunology 2007;120(6):1389-98. [PUBMED: PMID: 17910890]
57. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12. [MEDLINE: 7823387]
58. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. Journal of Investigative Dermatology 2011;131(1):67-73. [PUBMED: 20739951]
59. Thestrup-Pedersen K. Clinical aspects of atopic dermatitis. Clinical & Experimental Dermatology 2000;25(7):535-43. [MEDLINE: 11122225]
60. Weisshaar E, Apfelbacher A, Jäger G, Zimmermann E, Bruckner T, Diepgen T, et al. Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. British Journal of Dermatology 2006;155(5):957-64. [MEDLINE: 17034525]
61. Williams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ, et al. The UK Working Party's diagnostic criteria for atopic dermatitis. British Journal of Dermatology 1994;131(3):383-96. [MEDLINE: 7918015]
62. Williams HC. Clinical practice. Atopic dermatitis. New England Journal of Medicine 2005;352(22):2314-24. [MEDLINE: 15930422]
63. Woosley RL. Cardiac actions of antihistamines. Annual Review of Pharmacology & Toxicology 1996;36:233-52. [MEDLINE: 8725389]
64. Yanai K, Rogala B, Chugh K, Paraskakis E, Pampura AN, Boev R. Safety considerations in the management of allergic diseases: focus on antihistamines. Current Medical Research & Opinion 2012;28(4):623-42. [MEDLINE: 22455874]
65. Yosipovitch G, Goon AT, Wee J, Chan YH, Zucker I, Goh CL. Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. International Journal of Dermatology 2002;41(4):212-6. [MEDLINE: 12031029]
66. Zuberbier T. Chronic Urticaria. Current Allergy Asthma Reports 2012;12(4):267-72. [MEDLINE: 22638841]